Whitehawk Therapeutics (WHWK) FCF Margin (2018 - 2025)
Whitehawk Therapeutics' (WHWK) quarterly FCF Margin came in at 164.45% in Q1 2025, up 20011.0% year-on-year from N/an in Q1 2024, and up 30.28% on a QoQ basis from 235.86% in Q4 2024.
Whitehawk Therapeutics (WHWK) FCF Margin (2018 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 7 years of FCF Margin data on file, last reported at 164.45% in Q1 2025.
- On a quarterly basis, FCF Margin rose 20011.0% year-over-year to 164.45% in Q1 2025; TTM through Dec 2025 was 1363.65%, a 112810.0% decrease from a year earlier, with the FY2025 full-year figure at 1363.65%, down 112810.0% from the prior year.
- FCF Margin for Q1 2025 stood at 164.45%, up from 235.86% in the prior quarter.
- Over the last five years, FCF Margin for WHWK reached as high as 8802.5% in Q1 2021 and fell as low as 842.57% in Q1 2022.
- Historically, FCF Margin has averaged 335.68% across 5 years, with a median of 194.68% in 2024.
- Across the five-year window, FCF Margin plunged 964507 bps in 2022 and surged 47275 bps in 2023, its largest moves.
- Year by year, FCF Margin stood at 85.34% in 2021, then sank by 162 bps to 223.72% in 2022, then surged by 33 bps to 150.55% in 2023, then plunged by 57 bps to 235.86% in 2024, then soared by 30 bps to 164.45% in 2025.
- Per Business Quant data, the three most recent FCF Margin figures were 164.45% in Q1 2025, 235.86% in Q4 2024, and 194.68% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -164.45% |
| Dec 31, 2024 | -235.86% |
| Sep 30, 2024 | -194.68% |
| Jun 30, 2024 | -171.14% |
| Mar 31, 2024 | -364.56% |
| Dec 31, 2023 | -150.55% |
| Sep 30, 2023 | -185.17% |
| Jun 30, 2023 | -272.33% |
| Mar 31, 2023 | -369.81% |
| Dec 31, 2022 | -223.72% |
| Sep 30, 2022 | -188.24% |
| Jun 30, 2022 | -318.91% |
| Mar 31, 2022 | -842.57% |
| Dec 31, 2021 | -85.34% |
| Mar 31, 2021 | 8,802.50% |
| Dec 31, 2020 | -22.99% |
| Sep 30, 2020 | -6,833.24% |
| Jun 30, 2020 | 68.61% |
| Dec 31, 2018 | -288,868.14% |
| Sep 30, 2018 | -33.17% |